youtube_live
Q3 2026 earnings • in 5 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$2.55
arrow_downward
-6.25%(-0.17) 1D
US$2.53
arrow_downward
-0.78% (-0.020)bedtimeAfter hours
Closed: ኖቬም 5, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$2.68
High
US$2.68
Low
US$2.41
Mkt. cap
391.63 ሚ
Avg. vol.
2.35 ሚ
Volume
0.00
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.74
Beta
2.09
Shares outstanding
153.58 ሚ
No. of employees
87
Open
US$2.68
High
US$2.68
Low
US$2.41
Mkt. cap
391.63 ሚ
Avg. vol.
2.35 ሚ
Volume
0.00
52-wk high
US$3.94
52-wk low
US$1.66
EPS
-US$0.74
Beta
2.09
Shares outstanding
153.58 ሚ
No. of employees
87
News stories
From web sources and news partners
Investing.com UK
·
ከ19 ሰዓቶች በፊት
Jones Trading initiates Editas Medicine stock coverage with buy rating By Investing.com
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedኖቬም 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com